These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23769642)

  • 1. Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Timén ÅS; Bergare J; Mussie T; Bergström L
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4026-30. PubMed ID: 23769642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Mensonides-Harsema M; Cooper ME
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3500-4. PubMed ID: 23659855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirocyclic compounds, potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Eriksson T
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1883-6. PubMed ID: 23414842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Mensonides-Harsema M; Cooper ME; Eriksson T; Ivanova S; Bergström L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):108-12. PubMed ID: 24332486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.
    Gilchrist A; Gauntner TD; Fazzini A; Alley KM; Pyen DS; Ahn J; Ha SJ; Willett A; Sansom SE; Yarfi JL; Bachovchin KA; Mazzoni MR; Merritt JR
    Br J Pharmacol; 2014 Nov; 171(22):5127-38. PubMed ID: 24990525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.
    Pennell AM; Aggen JB; Sen S; Chen W; Xu Y; Sullivan E; Li L; Greenman K; Charvat T; Hansen D; Dairaghi DJ; Wright JJ; Zhang P
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1228-31. PubMed ID: 23374868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel series of human CCR1 antagonists.
    Xie YF; Sircar I; Lake K; Komandla M; Ligsay K; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2215-21. PubMed ID: 18329267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyrrolidine heterocycles as CCR1 antagonists.
    Merritt JR; James R; Paradkar VM; Zhang C; Liu R; Liu J; Jacob B; Chiriac C; Ohlmeyer MJ; Quadros E; Wines P; Postelnek J; Hicks CM; Chen W; Kimble EF; O'Brien L; White N; Desai H; Appell KC; Webb ML
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5477-9. PubMed ID: 20708929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor.
    Chaturvedula PV; Pin S; Tholady G; Conway CM; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4719-22. PubMed ID: 22732695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel azaindazole CCR1 antagonist clinical candidates.
    Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
    Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2).
    Strunz AK; Zweemer AJ; Weiss C; Schepmann D; Junker A; Heitman LH; Koch M; Wünsch B
    Bioorg Med Chem; 2015 Jul; 23(14):4034-49. PubMed ID: 25766632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.
    Xie YF; Lake K; Ligsay K; Komandla M; Sircar I; Nagarajan G; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Dines K; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3367-72. PubMed ID: 17446072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
    Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
    FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of pyrazole amides as antagonists of CCR1.
    Harcken C; Sarko C; Mao C; Lord J; Raudenbush B; Razavi H; Liu P; Swinamer A; Disalvo D; Lee T; Lin S; Kukulka A; Grbic H; Patel M; Patel M; Fletcher K; Joseph D; White D; Amodeo L; Berg K; Brown M; Thomson DS
    Bioorg Med Chem Lett; 2019 Feb; 29(3):435-440. PubMed ID: 30455146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent benzimidazolone-based CGRP receptor antagonists.
    Theberge CR; Bednar RA; Bell IM; Corcoran HA; Fay JF; Hershey JC; Johnston VK; Kane SA; Mosser S; Salvatore CA; Williams TM; Zartman CB; Zhang XF; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6122-5. PubMed ID: 18947992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.
    Xiang MA; Chen RH; Demarest KT; Gunnet J; Look R; Hageman W; Murray WV; Combs DW; Patel M
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2987-9. PubMed ID: 15125974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.